Mechanism-based improvement in the therapeutic selectivity of 5-fu prodrug alone and under conditions of metabolic modulation

Oncology (Switzerland)

Volumn 54, Issue , 1997, Pages 7-11

  Rustum, Youcef M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Leucovorin; Modulation; UFT ; Uracil

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PRODRUG; TEGAFUR; UFT;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER REGRESSION; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; DRUG SELECTIVITY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG SYNERGISM; FLUOROURACIL; LEUCOVORIN; PRODRUGS; RATS; TEGAFUR; URACIL;

EID: 0031060464     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227738     Document Type: Article

References (7)

1. Fujii S, Kitano S, Ikenaka K, et al: Effect of Uracil and its derivatives on antitumor activity of 5-fluorouracil and l-(2-tetrahydrofuryl)-5-fiuorouracil. Gann 1978;69:763-772.
2. Fujii S, Kitano S, Ikenaka K, et al: Effect of coadministration of Uracil or cytosine on the antitumor activity of clinical dose of l-(2-tetra-hydrofuryl)-5-fluorouracil and level of 5-fluoro-Uracil in rodents. Gann 1979;70:209-214.
3. Taguchi T, Nakano Y, Fujii S, et al: Determination of 5-fluorouracil levels in tumors, blood and other tissues. Cancer Chemother 1978;5: 1167-1172.
4. Toide H, Akiyoshi H, Minato Y.et al Compar-ativestudies on metabolism of l-(2-tetrahydro-furyl)-5-fluorouracil and 5-fluorouracil. Gann 1977;68:553-560.
5. Kimura K, Suga S, Shimaji T, et al: Clinical basis of chemotherapy for gastric cancer with Uracil and l-(2-tetrahydrofuryl)-5-fluoroura-cil. Gastroenterol Jpn 1980:15:324-329.
6. Unemi N, Takeda S, Tajinta K, et al: Studies on combination therapy with l-2-tctrahydro-furyli-5-fluorouracil plus Uracil. Chemotherapy 1981;29:164-175.
7. Taguchi T, Nakano Y, Jiyuka K, et al: Effect of Uracil on the antitumor activity of Futraful. Gan To Kagaku Ryoho 1978,5:1161-1163.